Cancer Archives

Startup Scout 11 Jan 2019

This Company Automates Cancer Research from Bench to Bar Charts

In the academic city of Oxford, UK, the company Arctoris is working to make life easier for cancer lab researchers, letting them ‘order’ experiments online using its robotic facilities and data analysis tools. Mission: To cut down researchers’ workloads by automating cellular, molecular, and data analysis techniques in cancer research. As any molecular biologist will […]

January 11, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 7 Jan 2019

Sanofi Invests €80M in mRNA Cancer Vaccine Company

Sanofi is to make an €80M equity investment in the German biotech BioNTech, and the two have agreed to co-develop a cancer vaccine based on injecting messenger RNA into solid tumors. This agreement is an extension of Sanofi and BioNTech’s collaboration, which began in 2015. The two companies will continue to co-develop and co-commercialize a candidate […]

January 7, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 20 Dec 2018

Personalized Immunotherapy for Brain Cancer Succeeds in Clinical Trials

A European trial has proved the feasibility and efficacy of treating cancer with a personalized immunotherapy tailored to each patient. The phase I/II trial, run across six European centers, tested a combination of two personalized vaccines in patients with glioblastoma, an aggressive form of brain cancer. The first vaccine was designed to immunize the patients […]

December 20, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Dec 2018

Antibody Hitting Tumor Self-Destruct Button Passes Phase I

A first-in-class antibody cancer treatment, from the French company Netris Pharma, has shown good safety and anti-tumor effects in a phase I trial in patients with advanced solid tumors. The antibody met the trial’s primary objective of good tolerability in the 19 recruited patients. In addition, the antibody helped to stabilize the disease and shrink […]

December 12, 2018 - 2 minutesmins - By Jonathan Smith

carthera brain cancer ultrasound glioblastoma cells cover

News and Trends 12 Dec 2018

Ultrasound Brain Cancer Therapy Gets €9M Series B Funding

A Series B funding round has bagged the French company CarThera €9M to fund the clinical development of an ultrasound brain cancer therapy. “The objective was for €8M, and we raised €1M more than expected,” Frederic Sottilini, CEO of CarThera, said to me. “That was very positive for us.” CarThera’s therapy uses a beam of ultrasound […]

December 12, 2018 - 3 minutesmins - By Jonathan Smith

News and Trends 10 Dec 2018

Scientists Repurpose Skin Cells to Fight Cancer

Researchers have reprogrammed skin cells to make them behave like immune cell sentinels called dendritic cells, which can recruit the immune system to fight tumors. This discovery makes a step toward better cancer immunotherapy. “We are merging two different areas of research,” Carlos-Filipe Pereira, from Lund University, Sweden, said to me. “One of them is […]

December 10, 2018 - 3 minutesmins - By Jonathan Smith

maat pharma gut microbiome therapy cancer

News and Trends 4 Dec 2018

Microbiome Therapy Shows Early Promise in Cancer Patients

A clinical trial run by MaaT Pharma has shown that restoring the microbiome of patients undergoing chemotherapy has potential to improve the outcome of patients with the blood cancer acute myeloid leukemia (AML). The microbes living in our gut can have a big influence on the success of cancer treatments. Some microorganisms are known to […]

December 4, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

aprea therapeutics anti cancer protein cover

News and Trends 3 Dec 2018

First-in-Class Cancer Drug Gets €50M Boost

The biopharmaceutical company Aprea Therapeutics has raised €50M to fund a Phase III trial of its first-in-class cancer drug candidate, which kills tumor cells by restoring the function of a key anti-cancer protein called p53. Aprea’s planned Phase III trial will test the company’s lead candidate small molecule drug combined with the chemotherapy drug azacitidine. […]

December 3, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 30 Nov 2018

Update: UK Biotech Scores £5M Series A to Boost Next-Generation Cancer Antibodies

Update (30/11/2018): IGEM Therapeutics has increased the total raised in Series A to £5M (€5.6M) with the participation of two new investors, Alsa Holdings and UCL Technology Fund. The funding will go towards the development of a new generation of antibody drugs for cancer. Published on 20/06/2017 IGEM Therapeutics has raised £2M (€2.3M) in Series A […]

November 30, 2018 - 2 minutesmins - By Melanie De Almeida

den bosch netherlands lava therapeutics cancer immunotherapy

Startup Scout 23 Nov 2018

This Biotech Arms Tumor-Busting Cells to Treat Cancer

In the medieval city of ‘s-Hertogenbosch, the Netherlands, Lava Therapeutics is developing a cancer immunotherapy that arms a rare type of immune cell called gamma delta T cells. Mission: Develop antibodies that recruit innate immune cells near tumors and activate them to kill cancer cells. T cells are immune cells that have a strong potential […]

November 23, 2018 - 3 minutesmins - By Jonathan Smith

Startup Scout 9 Nov 2018

This Biotech Uses Radioactive Chemicals to Diagnose Brain Cancer

In Athens, Greece, we find pro-Actina. This biotech is working on a method to diagnose brain cancer by measuring how ‘leaky’ the brain is. Mission: Founded in 2006, the company is working to improve glioma diagnosis by using a combination of CT scans and an injectable radioactive chemical tracer. Gliomas are the most common forms […]

November 9, 2018 - 3 minutesmins - By Jonathan Smith

News and Trends 5 Nov 2018

DNA Repair Treatment Shows Early Promise for Treating Cancer

Paris-based Onxeo has proved in humans the potential of a cancer treatment that interferes with DNA repair mechanisms. The therapy has potential to work in a wide range of tumors without cancer cells becoming resistant. Onxeo has reported preliminary results from an ongoing Phase I trial in which six different doses will be tested. […]

November 5, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us